Human melanoma inhibitory protein binds to the FN12-14 Hep II domain of fibronectin

King Tuo YipRaphael Stoll


The heparin binding site (Hep II) of fibronectin plays a major role in tumor cell metastasis. Its interaction with heparan sulfate proteoglycans occurs in a variety of physiological processes including focal adhesion and migration. The melanoma inhibitory activity (MIA) is an important protein that is functionally involved in melanoma development, progression, and tumor cell invasion. After its secretion by malignant melanoma cells, MIA interacts with fibronectin and thereby actively facilitates focal cell detachment from surrounding structures and strongly promotes tumor cell invasion and the formation of metastases. In this report, the authors have determined the molecular basis of the interaction of MIA with the Hep II domain of fibronectin based on nuclear magnetic resonance spectroscopic binding assays. The authors have identified the type III modules 12 to 14 of fibronectin's Hep II as the major MIA binding sites. These results now provide a new target protein-protein binding interface for the discovery of novel antimetastatic agents against malignant melanoma in the future.


Jan 1, 1989·Cancer Investigation·Martin J HumphriesKenneth M Yamada
Aug 1, 1981·The Journal of Investigative Dermatology·D F Mosher, L T Furcht
Nov 1, 1995·Journal of Biomolecular NMR·F DelaglioA Bax
Sep 1, 1995·Cancer Metastasis Reviews·S K AkiyamaKenneth M Yamada
Jan 5, 1996·The Journal of Biological Chemistry·A BosserhoffReinhard Buettner
Nov 29, 1996·Science·S B ShukerS W Fesik
Mar 1, 1997·Frontiers in Bioscience : a Journal and Virtual Library·S JohanssonL Lohikangas
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Dec 19, 1998·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A BosserhoffR Hein
Nov 23, 2000·Glycobiology·Barbara Mulloy, Mark J Forster
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·Julie C LougheedTracy M Handel
Mar 9, 2002·Journal of Biomolecular NMR·Maurizio PellecchiaDaniel S Sem
May 7, 2002·Journal of Biomolecular NMR·Julie C LougheedTracy M Handel
Sep 24, 2002·Journal of Cell Science·Roumen Pankov, Kenneth M Yamada
Oct 16, 2002·The Journal of Biological Chemistry· SachchidanandIain D Campbell
Feb 13, 2003·Journal of the American Chemical Society·Cyril DominguezAlexandre M J J Bonvin
Feb 20, 2003·Protein Science : a Publication of the Protein Society·Raphael StollTad A Holak
Oct 14, 2003·Drug Discovery Today·Miles CongreveHarren Jhoti
Nov 15, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Anja-Katrin BosserhoffTad A Holak
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mu GaoKlaus Schulten
Sep 22, 2005·Journal of the American Chemical Society·Loyola D'SilvaTad A Holak
Sep 22, 2006·Journal of Cell Science·Jonathan D HumphriesMartin J Humphries
Nov 30, 2006·Biological Chemistry·Raphael StollAnja-Katrin Bosserhoff
Oct 24, 2007·Journal of Biomolecular NMR·Frank H SchumannHans Robert Kalbitzer
Jun 10, 2008·Current Protein & Peptide Science·Raphael Stoll, A Bosserhoff
Apr 20, 2010·Journal of Computer-aided Molecular Design·Daniel Seeliger, Bert L de Groot
Aug 6, 2010·The Journal of Biological Chemistry·Sascha KarassekRaphael Stoll
Aug 10, 2010·Annual Review of Cell and Developmental Biology·Purva SinghJean E Schwarzbauer
Sep 20, 2011·Fibrogenesis & Tissue Repair·Wing S To, Kim S Midwood
Oct 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kevin B KimJohn M Kirkwood
Mar 21, 2012·Proceedings of the National Academy of Sciences of the United States of America·Till MaurerGuowei Fang
May 17, 2012·Journal of Chemical Information and Modeling·John J IrwinRyan G Coleman
Jun 16, 2012·Biochemistry·Duncan E ScottChris Abell
Mar 22, 2013·PloS One·Mikael TrelletAlexandre M J J Bonvin
Aug 21, 2013·Biochemistry·Austin D Vogt, Enrico Di Cera
Oct 12, 2013·Cancer Treatment and Research·Antonio M GrimaldiPaolo A Ascierto
Dec 18, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Miguel F SanmamedAlvaro González
Jan 17, 2014·International Journal of Computational Biology and Drug Design·Jamal Shamsara
Feb 4, 2014·Biochimica Et Biophysica Acta·D NikitovicG N Tzanakakis
May 7, 2016·Scientific Reports·King Tuo YipRaphael Stoll


Jun 30, 2017·Biointerphases·Tobias Weidner

Related Concepts

MIA protein, human
Protein Domain
Neoplasm Proteins
Plasma Protein Binding Capacity
Extracellular Matrix Proteins
Protein NMR Spectroscopy
Molecular Docking Analysis

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Related Papers

Histology and Histopathology
Jennifer SchmidtAnja-Katrin Bosserhoff
International Journal of Cancer. Journal International Du Cancer
Jennifer Schmidt, Anja-Katrin Bosserhoff
Biological Chemistry
Raphael StollAnja-Katrin Bosserhoff
Advances in Experimental Medicine and Biology
A Woods, J R Couchman
© 2021 Meta ULC. All rights reserved